Page last updated: 2024-11-06

phentolamine and Leukemia, Promyelocytic, Acute

phentolamine has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bang, BE1
Aarbakke, J1
Sager, G1

Other Studies

1 other study available for phentolamine and Leukemia, Promyelocytic, Acute

ArticleYear
Epinephrine induces beta-adrenergic desensitization and differentiation of HL-60 cells.
    Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:4

    Topics: Adenylyl Cyclases; Cell Differentiation; Epinephrine; Humans; Leukemia, Promyelocytic, Acute; Phento

1993